Comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPen.

Practical aspects of insulin pen devices. J Diabetes Sci Technol (2010) 1.33

Do different body colors and labels of insulin pens enhance a patient's ability to correctly identify pens for injecting long-acting versus short-acting insulins? J Diabetes Sci Technol (2011) 1.24

Correct use of a new reusable insulin injection pen by patients with diabetes: a design validation study. J Diabetes Sci Technol (2010) 1.20

Dosing accuracy and insulin flow rate characteristics of a new disposable insulin pen, FlexTouch, compared with SoloSTAR. J Diabetes Sci Technol (2013) 1.11

Injection force of reusable insulin pens: Novopen 4, Lilly Luxura, Berlipen, and ClikSTAR. J Diabetes Sci Technol (2011) 1.04

What can we learn from patient-reported outcomes of insulin pen devices? J Diabetes Sci Technol (2011) 1.04

Comparison of patient preference for two insulin injection pen devices in relation to patient dexterity skills. J Diabetes Sci Technol (2012) 0.92

Dosing Accuracy of Two Disposable Insulin Pens According to New ISO 11608-1: 2012 Requirements. J Diabetes Sci Technol (2015) 0.89

A review of insulin pen devices and use in the elderly diabetic population. Clin Med Insights Endocrinol Diabetes (2010) 0.89

An evaluation of prefilled insulin pens: a focus on the Next Generation FlexPen(®). Med Devices (Auckl) (2010) 0.86

Attributes Influencing Insulin Pen Preference Among Caregivers and Patients With Diabetes Who Require Greater Than 20 Units of Mealtime Insulin. J Diabetes Sci Technol (2016) 0.78

Discrete Choice Experiment Attribute Selection Using a Multinational Interview Study: Treatment Features Important to Patients with Type 2 Diabetes Mellitus. Patient (2017) 0.78

Comment on comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPen. Diabetes Educ (2010) 0.75

Is the indicator magnifying window for insulin pens helpful for elderly diabetic patients? Diabetes Metab J (2013) 0.75

Accuracy of the 5-day FreeStyle Navigator Continuous Glucose Monitoring System: comparison with frequent laboratory reference measurements. Diabetes Care (2007) 3.65

International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: analysis of efficacy and safety data in a large surgical cohort. Surgery (2006) 2.05

Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study. JAMA (2003) 1.97

Venous and arterial thromboembolism in severe sepsis. Thromb Haemost (2008) 1.50

Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes. Clin Ther (2007) 1.47

Does A1c consistently reflect mean plasma glucose? J Diabetes (2010) 1.39

Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial. Diabetes Care (2004) 1.37

Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia. Diabetes Care (2008) 1.35

United States patient preference and usability for the new disposable insulin device Solostar versus other disposable pens. J Diabetes Sci Technol (2008) 1.20

Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison. Clin Ther (2007) 1.10

Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo-controlled trial. Arch Phys Med Rehabil (2003) 1.09

Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies. Crit Care (2005) 1.07

Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus. Endocr Pract (2010) 1.05

Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria. Nephrol Dial Transplant (2007) 1.01

Ease of use and patient preference injection simulation study comparing two prefilled insulin pens. Curr Med Res Opin (2010) 0.93

Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study. Clin Ther (2006) 0.92

Effect of teriparatide [rhPTH(1-34)] on BMD when given to postmenopausal women receiving hormone replacement therapy. J Bone Miner Res (2005) 0.90

International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: analysis of efficacy and safety data in a large surgical cohort. Surgery (2007) 0.88

Effects of blood glucose rate of changes on perceived mood and cognitive symptoms in insulin-treated type 2 diabetes. Diabetes Care (2007) 0.88

Population exposure-response modeling of metformin in patients with type 2 diabetes mellitus. J Clin Pharmacol (2008) 0.86

Insulin pharmacokinetics following dosing with Technosphere insulin in subjects with chronic obstructive pulmonary disease. Curr Med Res Opin (2010) 0.83

Regional and racial differences in smoking and exposure to secondhand smoke: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Prev Chronic Dis (2011) 0.82

Hormonal and metabolic effects of morning or evening dosing of the dipeptidyl peptidase IV inhibitor vildagliptin in patients with type 2 diabetes. Br J Clin Pharmacol (2010) 0.77